Clinical characteristics, treatment, and management of pembrolizumab induced hemophagocytic lymphohistiocytosis

被引:0
|
作者
Chunjiang Wang
Wei Sun
Zuojun Li
Tian Wu
Weijin Fang
机构
[1] Central South University,Department of Pharmacy, The Third Xiangya Hospital
来源
Investigational New Drugs | 2023年 / 41卷
关键词
Hemophagocytic lymphohistiocytosis; Pembrolizumab; Immune checkpoint inhibitors; Hyperferriinemia;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:834 / 841
页数:7
相关论文
共 50 条
  • [1] Clinical characteristics, treatment, and management of pembrolizumab induced hemophagocytic lymphohistiocytosis
    Wang, Chunjiang
    Sun, Wei
    Li, Zuojun
    Wu, Tian
    Fang, Weijin
    INVESTIGATIONAL NEW DRUGS, 2023, 41 (06) : 834 - 841
  • [2] Clinical Features, Treatment, and Outcomes of Nivolumab-Induced Hemophagocytic Lymphohistiocytosis
    Sun, Jichun
    Luo, Panpan
    Guo, Yuge
    He, Yang
    Wang, Chunjiang
    JOURNAL OF IMMUNOTHERAPY, 2025, 48 (02) : 58 - 62
  • [3] Hemophagocytic Lymphohistiocytosis in a Patient with Rheumatoid Arthritis on Pembrolizumab for Lung Adenocarcinoma
    Akagi, Yu
    Awano, Nobuyasu
    Inomata, Minoru
    Kuse, Naoyuki
    Tone, Mari
    Yoshimura, Hanako
    Jo, Tatsunori
    Takada, Kohei
    Kumasaka, Toshio
    Izumo, Takehiro
    INTERNAL MEDICINE, 2020, 59 (08) : 1075 - 1080
  • [4] COVID-19 and Pembrolizumab-Induced Secondary Hemophagocytic Lymphohistiocytosis: a Case Report
    Luis Ramos-Ruperto
    Carmen Busca-Arenzana
    Juan Valdivieso
    Eduardo López-Granados
    Ángel Robles-Marhuenda
    SN Comprehensive Clinical Medicine, 2021, 3 (6) : 1412 - 1415
  • [5] Pembrolizumab-induced Autoimmune Hemolytic Anemia and Hemophagocytic Lymphohistiocytosis in Non-small Cell Lung Cancer
    Okawa, Sachi
    Kayatani, Hiroe
    Fujiwara, Keiichi
    Ozeki, Taichi
    Takada, Kenji
    Iwamoto, Yoshitaka
    Minami, Daisuke
    Sato, Ken
    Shibayama, Takuo
    INTERNAL MEDICINE, 2019, 58 (05) : 699 - 702
  • [6] Clinical Characteristics of Adult Hemophagocytic Lymphohistiocytosis in the Emergency Department
    Zhang, Fang-Jie
    Huang, Guo-Qing
    Li, Jia
    Xu, Ji
    Li, Xiang-Min
    Wang, Ai-Min
    INTERNATIONAL JOURNAL OF GENERAL MEDICINE, 2021, 14 : 4687 - 4694
  • [7] Clinical characteristics, treatment, and outcomes of pembrolizumab-induced uveitis
    Wu, Zhaoquan
    Sun, Wei
    Wang, Chunjiang
    INVESTIGATIONAL NEW DRUGS, 2024, 42 (05) : 510 - 517
  • [8] Clinical Characteristics of Hemophagocytic Lymphohistiocytosis Related to Kawasaki Disease
    Kim, Hyun Kwon
    Kim, Han Gyu
    Cho, Su Jin
    Hong, Young Mi
    Sohn, Sejung
    Yoo, Eun-Sun
    Chung, Wha-Soon
    Ryu, Kyung-Ha
    PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2011, 28 (03) : 230 - 236
  • [9] Treatment of hemophagocytic lymphohistiocytosis
    Wang, Yini
    Wang, Zhao
    CURRENT OPINION IN HEMATOLOGY, 2017, 24 (01) : 54 - 58
  • [10] Preoperative pembrolizumab-induced hemophagocytic lymphohistiocytosis in a patient with breast cancer: A case report
    Kawamura, Yukino
    Shimomura, Akihiko
    Taniyama, Tomoko
    Hirai, Hoshie
    Hashimoto, Kazuki
    Honda, Yayoi
    Kitagawa, Dai
    Nasu, Ryo
    Shimazu, Hiroshi
    Hangaishi, Akira
    Shimizu, Chikako
    ONCOLOGY LETTERS, 2025, 29 (03)